Franklin Resources
ORIC icon

Franklin Resources’s Oric Pharmaceuticals ORIC Stock Holding History

Franklin Resources’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Buy
1,452,835
+240,288
+20% +$2.73M ﹤0.01% 1017
2025
Q4 		$9.92M Buy
1,212,547
+31,218
+3% +$359K ﹤0.01% 1164
2025
Q3 		$14.2M Buy
1,181,329
+138,771
+13% +$1.46M ﹤0.01% 1064
2025
Q2 		$10.6M Buy
1,042,558
+19,768
+2% +$133K ﹤0.01% 1110
2025
Q1 		$5.71M Buy
1,022,790
+72,268
+8% +$632K ﹤0.01% 1301
2024
Q4 		$7.67M Buy
950,522
+63
+0% +$578 ﹤0.01% 1205
2024
Q3 		$9.07M Buy
950,459
+196,804
+26% +$1.95M ﹤0.01% 1160
2024
Q2 		$5.33M Buy
753,655
+3,139
+0.4% +$28.1K ﹤0.01% 1288
2024
Q1 		$10.3M Hold
750,516
– – ﹤0.01% 1069
2023
Q4 		$6.9M Buy
750,516
+105
+0% +$759 ﹤0.01% 1035
2023
Q3 		$4.54M Buy
750,411
+732,487
+4,087% +$6M ﹤0.01% 1114
2023
Q2 		$139K Buy
+17,924
New +$102K ﹤0.01% 2471
2020
Q3 		– Sell
-125,000
Closed -$3.2M – 1890
2020
Q2 		$3.2M Buy
+125,000
New +$3.99M ﹤0.01% 1065

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return